EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


September 15, 2016
Boston Marriott Copley Place,
Boston, MA

Thank you for attending Digital Medicine Connect

Where digital health and drug development merge to transform medicine

How will new digital technologies impact disease management and healthcare over the next decade?

The last five years have seen an unprecedented eruption in technological and digital health advances.  These new technologies and products are poised to have a significant impact on disease management and healthcare over the next decade. This report takes an in-depth look at the current and future influence of digital medicine on the health ecosystem.

Whitepaper authored by Forbes contributor, Nicole Fisher, and features insights from Evidation Health, Hogan Lovells, J&J, NIH/PMI, Sanofi, StartUp Health, and key opinion leaders such as John Nosta and Unity Stoakes.

- Produced by EBD Group in collaboration with Hogan Lovells

A curated group of innovative digital medicine companies shared their plans for changing the way diseases will be monitored and treated in the future.

Mobilize cross-sector partnerships

Taking place at the 9th annual BioPharm America, Digital Medicine Connect is designed to offer expanded networking and cross-pollination of ideas across the drug development, pharma and digital health ecosystems.

Explore thought leadership

Panels will discuss the unprecedented challenges facing digital medicine stakeholders today as they work to deliver clinically and economically impactful solutions in a saturated, emerging business environment.

Hear from trailblazers of modern medicine

Digital Medicine Connect will feature a curated group of entrepreneurs, researchers and executives who will present their plans to bring transformational products to market that will help reshape healthcare.

BioPharm America offers expanded networking opportunities

BioPharm America is a three-day partnering conference that gives biotech, pharma and investment executives from around the world an opportunity to identify and enter into strategic relationships through one-to-one meetings, company presentations and networking events. 

Attendees of Digital Medicine Connect have the opportunity to also attend BioPharm America programs and presentations taking place on September 15.

Learn more about BioPharm America.

A results-oriented conference

Our overriding mission is to help collaborations get started across the life science value chain.

To achieve our mission, we created a variety of partnering conferences that today have grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is attended by senior life science executives who attend not only for education, but more importantly to engage in tens of thousands of partnering meetings. These vital connections are the wellspring of deals that drive innovation in our industry.


Digital Medicine Connect took place during BioPharm America 2016. 

Silver Sponsor

EBD Group: Facilitating collaborations across the life science value chain

We are experts in bringing people together, whether at our events or virtually, year-round. Our events and services enable life science companies to identify business and licensing opportunities that are essential to their success. Our expertise is what has made EBD Group the leading partnering firm for the global life science industry since 1993.